Daptomycin NEW
| Price | $62 | $90 | $171 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-07-25 |
Product Details
| Product Name: Daptomycin | CAS No.: 103060-53-3 |
| Purity: 99.61% | Supply Ability: 10g |
| Release date: 2025/07/25 |
Product Introduction
Bioactivity
| Name | Daptomycin |
| Description | Daptomycin (LY146032) is a cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA. |
| In vivo | Administering daptomycin at a dosage of 10 mg/kg twice daily significantly reduced the amount of organisms per kidney compared to infected untreated controls within 48 hours of treatment initiation. Although a 20 mg/kg dose administered once daily is less effective, it still significantly lowers colony counts after 4 days of therapy, with its efficacy being comparable to that of vancomycin or vancomycin-gentamicin administered twice daily[4]. |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 32.4 mg/mL (19.99 mM), Sonication is recommended. DMSO : 45 mg/mL (27.77 mM), Sonication is recommended. |
| Keywords | RNASynthesis | RNA Synthesis | LY-146032 | LY 146032 | Inhibitor | inhibit | DNASynthesis | DNA synthesis | DNA Synthesis | Daptomycin | Bacterial | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Dehydroacetic acid sodium | Ampicillin sodium | Methyl anthranilate | Kanamycin sulfate | Urethane | Sulfamethoxazole sodium | Guanidine hydrochloride | Doxycycline | Thymidine | Isoeugenol | Dimethyl sulfoxide |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | EMA Approved Drug Library | Natural Product Library | Drug Repurposing Compound Library | Microbial Natural Product Library | FDA-Approved Drug Library | Natural Product Library for HTS | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-06-11 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $80.70/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
| $150.00/1kg |
Henan Bao Enluo International TradeCo.，LTD
|
2023-06-02 | ||
| $8.00/1g |
Qiuxian Baitai New Material Co., LTD
|
2021-11-24 | ||
| $150.00/1ASSAYS |
Hebei Mingeng Biotechnology Co., Ltd
|
2021-11-22 | ||
| $10.00/1Kg/Bag |
Hebei Zhanyao Biotechnology Co. Ltd
|
2021-11-10 | ||
| $0.00/1Kg/Bag |
VIP5Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-10-14 | |
| $0.00/10mg |
Guangzhou PI PI BIOTECH INC
|
2021-09-16 | ||
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-07-16 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY